In the Media
July 30, 2019 Pinning Down Prescription Drug Prices
November 26, 2018 Pharma-backed group attacks a controversial cost-shifting insurance tool by scaring employers
June 5, 2018 A new cost-shifting maneuver is causing average net prices for drugs to fall
April 18, 2018 Which drug makers are most vulnerable to a new cost-shifting maneuver?
March 30, 2018 Wholesale drug prices may be rising, but rebates are taking a bigger bite
October 11, 2017 J&J is struggling in Puerto Rico, but claims to be making progress
September 19, 2017 Brand-name drug prices are still rising, just not as fast as before
November 16, 2016 Drug prices don’t budge even after pressure from Congress
October 10, 2018 Get ready for a Rx drug-supplement war
September 11, 2018 Copay Coupons and their Nemeses: What is Driving Drug Price Declines, and Who is Paying?
September 4, 2018 – Insurance tactic drags down U.S. drug prices in second quarter: analyst
June 5, 2018 U.S. drug prices hit by insurer tactic against copay assistance: analysis
July 18, 2018 When insurers drop medications for cheap alternatives, the effects can be devastating for some patients
March 5, 2019 FDA chief Gottlieb resigns as agency battles teen vaping, opioid crisis
June 5, 2018 Drug prices are falling—but not necessarily in a way that helps patients
March 15, 2018 Which firms profit most from America’s health-care system
February 12, 2018 Trump’s big promises on drug costs followed by modest steps
August 9, 2017 Amid EpiPen price woes, alternatives emerge — but at a questionable cost
February 22, 2017 Lawsuit accuses drug makers of conspiring to hike insulin prices
April 27, 2016 Valeant CEO admits “regret” over drug price hikes
December 5, 2017 What the CVS-Aetna deal means for the future of health care
November 7, 2016 The bizarre reason two competing drug prices rose in tandem
May 12, 2016 Secret rebates, coupons and exclusions: how the battle over high drug prices is really being fought
March 18, 2016 A window into one of the most baffling things about drug prices
December 20, 2018 – Pharma Prepares to Raise Prices in 2019 With a Wink to Trump
July 10, 2018 – Drugmakers Cancel Price Hikes After California Law Takes Effect
May 3, 2018 Glaxo’s Advair Is the $100 Billion Asthma Drug That Won’t Die
November 7, 2017 This Is How Amazon Could Invade the Pharmacy Business
September 10, 2015 Big Pharma’s Foe Takes Victory Lap as Drug Price Increases Slow
May 8, 2014 Big Pharma’s Favorite Prescription: Higher Prices
June 20, 2016 A Market-Based Proposal for Controlling Drug Prices
June 12, 2014 Valeant Pharma’s Arguments About Drug Research Are Misleading And Wrong
May 22, 2014 Who’s The Best In Drug Research? 22 Companies Ranked
May 7, 2014 Is This How We’ll Cure Cancer?
December 26, 2013 Matt Herper’s Most-Read Stories Of 2013
December 5, 2013 ObamaCare Raises Health Insurance Premiums, Especially For The Young
January 31, 2013 The Flu Season Is A Shot In The Arm For Vaccine Makers?
July 9, 2012 Hidden Danger: Why The Supreme Court Ruling Might Make Medicaid Shrink
March 21, 2012 Why Big Pharma’s Constant Price Increases Could Backfire
July 7, 2011 Pfizer Decides Against Radical Surgery
June 1, 2011 A Pfizer Break Up? Maybe Not Such A Great Idea
May 19, 2010 Lipitor Factory Is One Pfizer Casualty
January 20, 2010 What’s Next For Health Care Companies?
May 8, 2014 Sanofi’s success shows benefit of global approach in drugs R&D
February 5, 2019 Flip the Script: Drugmakers Blame Middlemen for Price Increases
March 25, 2018 Glaxo CEO Dispenses Bitter Pill to Fix R&D
May 2, 2017 Revolt Against Sky-High Drug Prices Prompts a Pioneer to Cash Out
April 30, 2017 Drug Makers Take Page From Hollywood to Spread the Risk
December 1, 2015 Why the U.S. Pays More Than Other Countries for Drugs
June 25, 2014 Sick Drawn to New Coverage in Health-Law Plans
June 18, 2014 – Premiums Rise at Big Insurers, Fall at Small Rivals Under Health Law
June 10, 2014 – Bid for Allergan Puts Valeant’s Research and Development Cuts Under Scrutiny
May 7, 2014 The Great Pharmaceutical Garage Sale of 2014 (Q&A with Richard Evans)
April 14, 2014 CBO Projects Lower Premiums in Health-Insurance Exchanges
September 3, 2013 The Morning Ledger: Health Care and Hiring Loom Large This Fall
September 25, 2012 Health Firms Size Up Election Outcomes
July 1, 2012 Health Law Battle Enters Round 2
June 29, 2012 How Low Might Medicare’s Drug Payout Go?
March 17, 2011 Drug Prices Rise Despite Calls for Cuts
March 17, 2011 Drug Price Increases Come As Companies Peer Over Patent Cliff
February 26, 2019 Cat Bites The Hand That Feeds; Hospital Bills $48,512
February 26, 2019 Pharmaceutical Company CEOs Face Grilling In Senate Over High Drug Prices
September 21, 2016 Mylan CEO Claims EpiPens Aren’t As Profitable As Everyone Thinks
August 25, 2016 Discounts Aren’t Enough to Halt Outrage At High EpiPen Prices
January 25, 2016 Fight To Lower Drug Prices Forces Some To Switch Medication
May 16, 2013 Pfizer Goes Direct With Viagra Sales To Men
September 12, 2012 How Cheap Can Lipitor Get? Try Free
May 31, 2012 More Americans Are Checking Prices Before Getting Health Care
January 13, 2012 Drugmakers Boost Prices, Despite Political Risks
January 7, 2011 If Drug Copays Have You Down, Check For A Coupon
January 20, 2010 Prospects For Health Overhaul Dim After Massachusetts Vote
January 6, 2018 Humira’s Best-Selling Drug Formula: Start at a High Price. Go Higher.
March 28, 2017 Severe Eczema Drug Is Approved by F.D.A.; Price Tag Is $37,000 a Year
November 17, 2009 Analyst Doubts Health Overhaul Can Pass
February 22, 2010 Evans Interview on Obama Health-Care Plan: Video – Bloomberg
December 28, 2009 Evans Intervew on Health-Care Legislation: Video – Bloomberg
May 25, 2012 Analysis: HMO stocks may struggle over health claim costs